Skip to main content
. 2022 Sep 2;27(17):5655. doi: 10.3390/molecules27175655

Figure 5.

Figure 5

Nerolidol does not compete for binding at the active site of DAGLβ. (A) DAGL-binding probe HT-01 is competed by DAGLβ blocker KT109 (100 nM) but not by nerolidol. (B) Summary of results from 2 experiments. NS by one tailed t-test vs. 1.0 (1.0 = no effect).